Table 3.

Subjects with IgG autoantibodies.

Group	Age	Sex	Atopy	Rhinosinusitis	Severity	OCS	FEV1	FEV1/FVC	Blood eosinophils (cell/mL)	Total IgE	Anti-EPX IgE	Anti-ECP IgE	Anti-EPX IgG	Anti-ECP IgG
Asthma	16	Female	Yes	No	Severe	2	77,3	0,67	132	122	Yes	Yes	Yes	Yes
Asthma	25	Female	Yes	Yes	Moderate	0	80	0,81	221	300	Yes	Yes	Yes	Yes
Asthma	17	Male	No	No	Severe	2	70	0,61	128	111	Yes	Yes	Yes	No
Asthma	28	Female	Yes	Yes	Severe	1	75	0,7	314	1042	Yes	No	Yes	No
Asthma	17	Male	No	No	Severe	1	80	0,9	57	55	Yes	No	Yes	Yes
Asthma	24	Male	Yes	Yes	Moderate	0	98	0,85	315	888	Yes	No	Yes	Yes
Asthma	7	Female	Yes	No	Severe	2	77	0,7	205	333	No	Yes	No	Yes
Asthma	33	Male	Yes	No	Moderate	0	93	0,86	100	128	No	Yes	No	Yes
Asthma	12	Male	Yes	Yes	Severe	1	95	0,89	140	50	No	No	Yes	No
Asthma	18	Female	Yes	No	Moderate	0	102	0,78	156	156	No	No	Yes	No
Asthma	13	Male	Yes	No	Moderate	0	97	0,85	125	101	No	No	Yes	No
Asthma	14	Male	Yes	No	Moderate	0	89	0,85	126	101	No	No	Yes	No
Asthma	20	Female	Yes	No	Moderate	0	96	0,9	130	222	No	No	Yes	No
Asthma	35	Male	No	No	Moderate	0	93	0,71	135	132	No	No	Yes	No
Asthma	40	Male	Yes	No	Moderate	0	95	0,95	126	20	No	No	Yes	No
Asthma	50	Female	Yes	No	Severe	3	55	0,59	130	115	No	No	Yes	Yes
Asthma	45	Female	Yes	No	Moderate	0	101	0,8	120	113	No	No	No	Yes
Asthma	29	Female	No	No	Moderate	0	96	0,83	90	133	No	No	No	Yes
Control	10	Male	Yes	No	N/A	N/A	N/A	N/A	122	169	Yes	No	Yes	No
Control	30	Female	No	No	N/A	N/A	N/A	N/A	130	148	Yes	No	Yes	No
Control	20	Female	No	No	N/A	N/A	N/A	N/A	140	175	No	Yes	No	Yes
Control	24	Male	No	No	N/A	N/A	N/A	N/A	55	110	No	No	Yes	No
Control	33	Female	No	No	N/A	N/A	N/A	N/A	110	101	No	No	Yes	No
Control	41	Male	No	No	N/A	N/A	N/A	N/A	121	88	No	No	Yes	No
Control	46	Male	No	No	N/A	N/A	N/A	N/A	66	53	No	No	Yes	No
Control	30	Female	No	No	N/A	N/A	N/A	N/A	160	113	No	No	Yes	Yes
Control	33	Male	No	No	N/A	N/A	N/A	N/A	130	145	No	No	No	Yes
Control	34	Female	No	No	N/A	N/A	N/A	N/A	109	115	No	No	No	Yes

Asthma patients in control subjects with anti-EPX IgG or anti-ECP IgG. FVC: Forced vital capacity, FEV1: Forced expiratory volume. N/A: No apply. OCS: Cycles of oral systemic corticosteroid